Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Director/PDMR Notification

8 Apr 2021 07:00

RNS Number : 7513U
Aquis Exchange PLC
08 April 2021
 

8 April 2021

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Director/PDMR Notification

 

Aquis Exchange PLC (AQX.L), the exchange services group, has been notified that Alasdair Haynes, CEO of the Company, sold 160,000 ordinary shares of 10p each in the Company ("Ordinary Shares") on 7 April 2021 at a price of £6.50 per Ordinary Share. Part of the sale is a result of his divorce settlement agreed in July 2017. Following this, Alasdair Haynes now holds 1,331,551 Ordinary Shares in the Company, representing 4.9% of the Company's issued share capital.

 

This announcement contains inside information under UK MAR.

 

Enquiries:

 

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

Belinda Keheyan, Head of Marketing

+44 (0) 7768 078 110

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

Chris Clarke

Edward Thomas

Kane Collings

Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Emma Gabriel (Corporate Broking)

Jeremy Grime (Specialist Sales)

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

aquis@almapr.co.uk

Kieran Breheny

Faye Calow

 

Notes to editors:

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Alasdair Haynes

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer

b)

Initial notification/ Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Aquis Exchange plc

b)

LEI

 

213800IXJSF5E1SIW150

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

 

Ordinary shares of 10 pence each

 

ISIN: GB00BD5JNK30

b)

Nature of the transaction

 

Sale of shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£6.50

 

160,000

 

 

d)

Aggregated information

-Aggregated volume

-Price

 

 

n/a - as above

e)

Date of the transaction

 

07/04/2021

f)

Place of the transaction 

London Stock Exchange

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLASIIDIIL
Date   Source Headline
20th Nov 202412:03 pmRNSForm 8.3 - Aquis Exchange PLC
20th Nov 202411:52 amRNSForm 8 (OPD) - Aquis Exchange PLC
20th Nov 202411:21 amRNSForm 8.3 - Aquis Exchange plc
20th Nov 202410:38 amRNSForm 8.5 (EPT/RI)
20th Nov 20249:27 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20249:27 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20249:25 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20247:00 amRNSForm 8 (OPD) - Aquis Exchange PLC
20th Nov 20246:55 amGNWForm 8.5 (EPT/RI)-Aquis Exchange plc
19th Nov 20247:00 amRNSDirectorate Change
18th Nov 20244:10 pmRNSBlock Listing Six Monthly Return
18th Nov 202411:33 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:29 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:28 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:24 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:24 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:21 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:18 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:16 amRNSForm 8.3 - Aquis Exchange PLC
14th Nov 20244:02 pmBUSForm 8.3 - Aquis Exchange PLC - Opening Disclosure
14th Nov 20249:52 amRNSForm 8.5 (EPT/RI)
14th Nov 20247:49 amGNWForm 8.5 (EPT/RI)-Aquis Exchange Plc
13th Nov 20241:17 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Aquis Exchange PLC
13th Nov 202411:04 amRNSForm 8.5 (EPT/RI)
13th Nov 20249:35 amRNSForm 8.5 (EPT/RI)
13th Nov 20249:10 amGNWForm 8.5 (EPT/RI) - Aquis Exchange Plc
12th Nov 20242:40 pmPRNForm 8.3 - Aquis Exchange PLC
12th Nov 20241:24 pmRNSForm 8.3 - AQUIS EXCHANGE PLC
12th Nov 20241:05 pmGNWForm 8.3 - [AQUIS EXCHANGE PLC - Opening Disclosure - 11 11 2024] - (CGAML)
12th Nov 202412:20 pmRNSForm 8.3 - Aquis Exchange plc
12th Nov 202412:12 pmRNSForm 8.3 - Aquis Exchange PLC
12th Nov 202411:49 amRNSForm 8.3 - Aquis Exchange plc
12th Nov 202410:51 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Aquis Exchange plc
12th Nov 202410:32 amRNSForm 8.5 (EPT/RI)
12th Nov 202410:20 amBUSForm 8.3 - Aquis Exchange plc
12th Nov 20249:51 amRNSForm 8.5 (EPT/RI)
12th Nov 20248:40 amGNWForm 8.5 (EPT/RI) - Aquis Exchange Plc
11th Nov 20241:05 pmRNSRule 2.9 Announcement
11th Nov 202410:45 amRNSForm 8.3 - Aquis Exchange PLC
11th Nov 20247:00 amRNSOffer for Aquis Exchange PLC
19th Sep 20246:26 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSInterim Results
28th Aug 20247:00 amRNSTrading Update and Notice of Results
17th May 20247:00 amRNSBlock listing application
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.